Australian Quarantine and Inspection Services ISPM 15 FAQ
On 1 January 2006, Australia will begin a phase in of mandatory treatment requirements for all solid timber packing and dunnage. Mandatory treatment for solid timber packing and dunnage is being introduced to reduce the risk of pest or disease entry through this high risk commodity.
Australian Quarantine Inspection Services Notice 30 2005 06 ISPM 15
On 1 January 2006, Australia will begin a phase in of mandatory treatment requirements for all solid timber packing and dunnage. During this phase in period 1 January 2006 until 1 May 2006,
Bar Coding - Distribution
With Supply Chain Management taking on ever growing importance, today's trading environment demands a universal numbering and bar coding system for tracking and identifying goods that is universally understood by everyone (EAN Australia)
Shippers declaration of dangerous goods - Sample form
Failure to comply in all respects with the applicable Dangerous Goods Regulations may be in breach of the applicable law, subject to legal penalties. Declaration must not, in any circumstances, be completed and/or signed by a consolidator, a forwarder or Passenger Cargo or an IATA cargo agent.
Serial Shipping Container Code (SSCC) Implementation Guide - Transport
There are many reasons to use the Serial Shipping Container Code (SSCC) but the most compelling would be the primary benefit of speeding your products through the process of shipping and receiving.
Good Wholesale Practice (GWP)
STL Warehousing follow and comply with the requirements of GWP for the storage and handling of pharmaceutical and medical products.
Good Distribution Practice of medicinal products for human use. (GDP)
The Commission has published EU Guidelines on Good Distribution Practice (GDP) in 1994 ( 2 ). Revised guidelines were published in March 2013 ( 3 ) in order to take into account recent advances in practices for appropriate storage and distribution of medicinal products in the European Union, as well as new requirements introduced by Directive 2011/62/EU ( 4 ).
Overview of the new regulatory framework for in vitro diagnostic medical devices (IVDs)
A new regulatory framework commenced on 1 July 2010 that ensures all IVDs will undergo a level of regulatory scrutiny that is commensurate with the risks associated with their use. The framework adopts the philosophies and recommendations of the Global Harmonization Task Force (GHTF) for IVDs, ensuring that requirements are internationally aligned.
Australian regulatory guidelines for medical devices(ARGMD)
The Therapeutic Goods Administration (TGA) is part of the Australian Government Department of Health and Ageing, and is responsible for regulating medicines and medical devices.
The TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary.
Therapeutic Goods Act 1989
This compilation was prepared on 4 March 2005 taking into account amendments up to Act No. 8 of 2005. Prepared by the Office of Legislative Drafting and Publishing, Attorney-General's Department, Canberra